Centrexion Therapeutics

Centrexion Therapeutics is a clinical-stage biopharmaceutical company developing a broad pipeline of novel, non-opioid, non-addictive therapies for chronic pain and immunology. Its mechanism-driven approach spans topical, injectable, and oral modalities, with partnerships with Lilly, Boehringer Ingelheim, Sanofi, and NIH validating its scientific platform. The company aims to be the premier pain therapeutics powerhouse by addressing safety and efficacy gaps in current treatments.